Where BMI Is Used as a Threshold and the Criticism of Each Use

A 42-year-old man with a BMI of 33 is told by his surgeon that his hip replacement cannot be scheduled until his BMI drops below 30. A woman with a BMI of 31 is turned down for IVF on the NHS because her local Integrated Care Board uses a BMI 30 cut-off. A life insurance applicant with a BMI of 28 sees their premium loaded by 40%, no questions asked. Each of these people has hit a BMI gate that functions as an institutional rule, not a clinical diagnosis. What follows catalogues where those gates are set, who set them, what evidence was cited, and the published criticism of each use.

Bariatric Surgery Cut-Offs

NICE guideline CG189 (2022 update) sets a BMI of 40 or above, or 35 to 39.9 with at least one obesity-related comorbidity, as the eligibility line for publicly funded bariatric surgery in England and Wales. The NIH Consensus Development Conference from 1991 used the same BMI 40 mark, or BMI 35 with serious comorbidities. The American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity (IFSO) updated their indications in 2022 to BMI 35 regardless of comorbidity, and BMI 30 to 34.9 with metabolic disease. None of these lines are derived from a single trial that identified a safe operating BMI. The NICE evidence review draws from cohort studies showing that perioperative morbidity risk, surgical site infection, venous thromboembolism, and respiratory complications rise as BMI increases above 30. Mullen et al. (2008), in a cohort of 2,258 patients undergoing major intra-abdominal cancer surgery, reported increased complication rates at BMI 30 and above. The criticism is that BMI is a poor predictor of surgical risk for a single person because it does not distinguish fat mass from lean mass, does not capture fat distribution, and correlates poorly with metabolic fitness. A meta-analysis by Romero-Corral et al. (2008) found that BMI 30 has high specificity (about 95%) but low sensitivity (about 50%) for detecting excess body fat by DXA, meaning half of people with excess adiposity are missed at that cut-off. Screening fit patients out of surgery based on a number that misclassifies half of them is an equity criticism, not a safety one.

NHS and HFEA Criteria

The UK Human Fertilisation and Embryology Authority (HFEA) suggests a BMI of 19 to 30 for IVF eligibility, but this is guidance, not a statutory limit. Individual NHS Integrated Care Boards set their own rules. A systematic review by Maheshwari et al. (2007), covering 47 studies, found that BMI over 30 is associated with lower live birth rates per cycle, higher miscarriage rates, and increased risk of ovarian hyperstimulation syndrome. The evidence is real but the boundary is arbitrary. The same review notes that many studies do not control for confounding by age, duration of infertility, or polycystic ovary syndrome. The criticism has two strands. First, the misclassification problem: a woman with a BMI of 31 may have normal metabolic health, while a woman with a BMI of 28 may have insulin resistance that affects IVF outcomes more than weight does. Second, the stigma problem: fertility treatment is already emotionally and financially exhausting; a blanket exclusion based on BMI, without personal assessment of metabolic markers, has been described by the British Pregnancy Advisory Service as weight stigma and institutional discrimination. No study has identified a clean break in IVF success at BMI 30. The cut-off is a convenience line copied from the WHO obesity class I boundary, not a fertility-specific evidence point.

How Insurers Use BMI

Life, health, and critical illness insurers use BMI as a rating factor. The typical penalty point is BMI 30 or 35, with premium loadings that vary by product and the insurer's actuarial tables. The foundation is the BMI, mortality association: the Prospective Studies Collaboration (2009), pooling 900,000 adults across 57 studies, found the lowest all-cause mortality at BMI 22.5 to 25.0, with each 5 kg/m² increase above 25 associated with roughly 30% higher all-cause mortality. Aune et al. (2016), in a meta-analysis of 230 cohort studies with 30 million participants, confirmed a J-shaped curve with increased mortality below BMI 18.5 and above 25. The criticism is that the association is confounded by reverse causation (illness causes weight loss before death, inflating the mortality of low-BMI groups) and by smoking (smokers have lower BMI and higher mortality). Mendelian randomisation studies suggest the causal effect of higher adiposity on mortality is more linear than the observed J-curve implies. An insurer loading a premium on BMI 30 is applying a population association to a person whose metabolic health may be excellent. The American Medical Association's 2023 policy statement on BMI explicitly cautions against using BMI as a sole measure of health in insurance and employment contexts, citing its inability to reflect personal metabolic or body composition status.

Job Roles Where BMI Is a Gate

Some employers, particularly in fire services, law enforcement, and the military, use BMI 30 or 35 as a fitness-for-duty line. The rationale is that higher body mass may impair physical performance and increase injury risk. The evidence is thin. No study has shown that BMI alone predicts job performance better than a physical fitness test does. The criticism is twofold. First, BMI is an employment fitness gate that misclassifies muscular people: a firefighter with high lean mass and low body fat can have a BMI of 31 and be perfectly fit for duty. Second, the lines are applied without accommodation for body composition, age, or sex. The Equal Employment Opportunity Commission in the US has taken action against employers whose BMI policies had a disparate impact on female and minority workers, who tend to have higher BMIs at the same body fat percentage due to differences in body composition (Deurenberg et al., 1998). BMI is a screening tool, not a diagnostic: using it as a hiring or retention criterion is a category error that the WHO cut-offs were never designed for.

Elective Surgery Gates

Many UK NHS Integrated Care Boards have, until recently, used BMI 30 or 35 as a gate for elective hip and knee arthroplasty. The evidence cited is that elevated BMI is associated with higher revision rates and increased risk of surgical site infection. NICE guideline NG157 (2020) on joint replacement does not recommend BMI-based rationing. The criticism is that the line is not evidence-based for joint-specific outcomes: a patient with a BMI of 31 and healthy knee cartilage may be denied surgery, while a patient with BMI 29 and severe osteoarthritis receives it. The NICE position is that clinical need, not BMI, should determine access.

Transplant Surgery Rules

Transplant surgery uses a similar gate: many centres use BMI 35 to 40 as a relative contraindication for kidney transplant, citing poorer graft and patient survival in registry data (Lentine et al., 2012, n=200,000+ US kidney transplant candidates). The criticism here is that denying transplant to people with higher BMI may increase their mortality risk from end-stage renal disease far more than any surgical risk from obesity. The line may protect surgical statistics but harm patient outcomes overall.

The most common failure is treating a BMI line as a clinical truth rather than an institutional policy. A BMI number is a population screening tool adopted by the WHO in 1995 using epidemiological cut-points, not physiological boundaries. It sorts people into bands that were never designed to be personal gates for surgery, fertility treatment, insurance, or employment. When you face a BMI barrier, the question is not whether your weight is healthy. That question cannot be answered by a single anthropometric number. The question is whether the line was set on evidence that applies to you, and whether a personal assessment of your metabolic health and body composition can override it. Ask for the policy, ask for the evidence, ask for a personal evaluation. The answer may not go your way, but you will know whether the gate is evidence-based or administrative.